Trials / Sponsors / Lumen Bioscience, Inc.
Lumen Bioscience, Inc.
Industry · 7 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | G.I. Pharmacokinetics of LMN-401 in Individuals With Ileostomies Travelers Diarrhea | EARLY_Phase 1 | 2024-12-04 |
| Recruiting | LMN-201 for Prevention of C. Difficile Infection Recurrence Clostridioides Difficile Infection | Phase 2 / Phase 3 | 2024-08-29 |
| Recruiting | Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia Travelers Diarrhea | — | 2024-06-20 |
| Completed | A Study to Determine the Tolerability of Intranasal LMN-301 COVID-19 | Phase 1 | 2023-10-06 |
| Completed | LMN-101 in a Campylobacter Human Challenge Model Campylobacter Infections | Phase 2 | 2022-02-21 |
| Completed | Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With C. Diff. Infections | Phase 1 | 2021-08-18 |
| Completed | Safety and Pharmacokinetic Study of LMN-101 in Healthy Volunteers Campylobacter Jejuni Infection | Phase 1 | 2019-11-15 |